Urokinase Plasminogen Activator Upregulates Paraoxonase 2 Expression in Macrophages Via an NADPH Oxidase-Dependent Mechanism

OBJECTIVE—Macrophage foam cells are characterized by increased oxidative stress. Macrophage urokinase plasminogen activator (uPA) was shown to contribute to atherosclerosis progression. We hypothesized that uPA atherogenicity is related to its ability to increase macrophage oxidative stress. Increas...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Arteriosclerosis, thrombosis, and vascular biology thrombosis, and vascular biology, 2008-07, Vol.28 (7), p.1361-1367
Hauptverfasser: Fuhrman, Bianca, Khateeb, Jasmin, Shiner, Maayan, Nitzan, Orna, Karry, Rachel, Volkova, Nina, Aviram, Michael
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1367
container_issue 7
container_start_page 1361
container_title Arteriosclerosis, thrombosis, and vascular biology
container_volume 28
creator Fuhrman, Bianca
Khateeb, Jasmin
Shiner, Maayan
Nitzan, Orna
Karry, Rachel
Volkova, Nina
Aviram, Michael
description OBJECTIVE—Macrophage foam cells are characterized by increased oxidative stress. Macrophage urokinase plasminogen activator (uPA) was shown to contribute to atherosclerosis progression. We hypothesized that uPA atherogenicity is related to its ability to increase macrophage oxidative stress. Increased macrophage oxidative stress in turn was shown to enhance PON2 expression. In the present study we investigated the effect of uPA on macrophage PON2 expression in relation to cellular oxidative stress. METHODS AND RESULTS—uPA increased PON2 expression in THP-1 macrophages in a dose-dependent manner. This effect required uPA/uPAR interaction and was abolished by cell treatment with antioxidants. uPA increased macrophage oxidative stress, measured by increased lipid peroxides, reactive oxygen species formation, superoxide anion release, and cell-mediated LDL oxidation. These effects were related to uPA-mediated activation of NADPH oxidase, and could not be reproduced in mouse peritoneal macrophages (MPM) harvested from p47 mice, suggesting a causal relationship between NADPH oxidase activation and the effects of uPA on macrophage oxidative stress and PON2 expression. Finally, MPM from PON2 mice were more susceptible to uPA-induced cellular oxidative stress than wild-type MPM, suggesting that PON2 protects against uPA-stimulated macrophage oxidative stress. CONCLUSIONS—Upregulation of macrophage PON2 may provide a compensatory protective mechanism against uPA-stimulation of macrophage oxidative stress during atherogenesis.
doi_str_mv 10.1161/ATVBAHA.108.166041
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69235184</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69235184</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4548-42b003e5335f163df215f77c57258613f29e00de06ad552d34083705f10907ca3</originalsourceid><addsrcrecordid>eNpFkU9v0zAYhy0EYqPwBTggX-CW8vpv0mPYBkXaWA_rrpGXvGnNEruzE9ZJ-_C4awQHy37l5_eT_JiQjwzmjGn2tby5_VYuyzmDYs60BslekVOmuMykFvp1OkO-yJSW_IS8i_E3AEjO4S05YYUUugB5Sp7Xwd9bZyLSVWdib53foKNlPdg_ZvCBrncBN2NnBox0ZYLxe_9Cc3qxT1cxWu-odfTK1MHvtmaTuFtrqHH0V3m-WtLrvW1SIDvHHboG3UCvsN4aZ2P_nrxpTRfxw7TPyPr7xc3ZMru8_vHzrLzMaqlkkUl-ByBQCaFapkXTcqbaPK9VzlWhmWj5AgEaBG0apXgjJBQihwTDAvLaiBn5cuzdBf8wYhyq3sYau8449GOs9IILdXAyI_wIprfEGLCtdsH2JjxVDKqD82pynuaiOjpPoU9T-3jXY_M_MklOwOcJMLE2XRuMq238x3GQKi9eiuSRe_TdgCHed-MjhmqLphu21eH3hAaVcYAC8jRmafFC_AX5X5kp</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69235184</pqid></control><display><type>article</type><title>Urokinase Plasminogen Activator Upregulates Paraoxonase 2 Expression in Macrophages Via an NADPH Oxidase-Dependent Mechanism</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><source>Alma/SFX Local Collection</source><creator>Fuhrman, Bianca ; Khateeb, Jasmin ; Shiner, Maayan ; Nitzan, Orna ; Karry, Rachel ; Volkova, Nina ; Aviram, Michael</creator><creatorcontrib>Fuhrman, Bianca ; Khateeb, Jasmin ; Shiner, Maayan ; Nitzan, Orna ; Karry, Rachel ; Volkova, Nina ; Aviram, Michael</creatorcontrib><description>OBJECTIVE—Macrophage foam cells are characterized by increased oxidative stress. Macrophage urokinase plasminogen activator (uPA) was shown to contribute to atherosclerosis progression. We hypothesized that uPA atherogenicity is related to its ability to increase macrophage oxidative stress. Increased macrophage oxidative stress in turn was shown to enhance PON2 expression. In the present study we investigated the effect of uPA on macrophage PON2 expression in relation to cellular oxidative stress. METHODS AND RESULTS—uPA increased PON2 expression in THP-1 macrophages in a dose-dependent manner. This effect required uPA/uPAR interaction and was abolished by cell treatment with antioxidants. uPA increased macrophage oxidative stress, measured by increased lipid peroxides, reactive oxygen species formation, superoxide anion release, and cell-mediated LDL oxidation. These effects were related to uPA-mediated activation of NADPH oxidase, and could not be reproduced in mouse peritoneal macrophages (MPM) harvested from p47 mice, suggesting a causal relationship between NADPH oxidase activation and the effects of uPA on macrophage oxidative stress and PON2 expression. Finally, MPM from PON2 mice were more susceptible to uPA-induced cellular oxidative stress than wild-type MPM, suggesting that PON2 protects against uPA-stimulated macrophage oxidative stress. CONCLUSIONS—Upregulation of macrophage PON2 may provide a compensatory protective mechanism against uPA-stimulation of macrophage oxidative stress during atherogenesis.</description><identifier>ISSN: 1079-5642</identifier><identifier>EISSN: 1524-4636</identifier><identifier>DOI: 10.1161/ATVBAHA.108.166041</identifier><identifier>PMID: 18436804</identifier><identifier>CODEN: ATVBFA</identifier><language>eng</language><publisher>Philadelphia, PA: American Heart Association, Inc</publisher><subject>Acetophenones - pharmacology ; Animals ; Antioxidants - pharmacology ; Aryldialkylphosphatase - biosynthesis ; Aryldialkylphosphatase - genetics ; Aryldialkylphosphatase - metabolism ; Atherosclerosis (general aspects, experimental research) ; Atherosclerosis - enzymology ; Atherosclerosis - metabolism ; Biological and medical sciences ; Blood and lymphatic vessels ; Cardiology. Vascular system ; Cardiovascular system ; Cell Line, Tumor ; Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous ; Enzyme Activation ; Enzyme Induction ; Humans ; Lipid Peroxidation ; Lipoproteins, LDL - metabolism ; Macrophages - drug effects ; Macrophages - enzymology ; Macrophages - metabolism ; Medical sciences ; Mice ; Mice, Inbred BALB C ; Mice, Inbred C57BL ; Mice, Knockout ; Miscellaneous ; NADPH Oxidases - deficiency ; NADPH Oxidases - genetics ; NADPH Oxidases - metabolism ; Oxidative Stress - drug effects ; Pharmacology. Drug treatments ; Plant Extracts - pharmacology ; Punicaceae ; Reactive Oxygen Species - metabolism ; Receptors, Cell Surface - deficiency ; Receptors, Cell Surface - genetics ; Receptors, Cell Surface - metabolism ; Receptors, Urokinase Plasminogen Activator ; RNA, Messenger - metabolism ; Urokinase-Type Plasminogen Activator - metabolism</subject><ispartof>Arteriosclerosis, thrombosis, and vascular biology, 2008-07, Vol.28 (7), p.1361-1367</ispartof><rights>2008 American Heart Association, Inc.</rights><rights>2008 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4548-42b003e5335f163df215f77c57258613f29e00de06ad552d34083705f10907ca3</citedby><cites>FETCH-LOGICAL-c4548-42b003e5335f163df215f77c57258613f29e00de06ad552d34083705f10907ca3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=20457841$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18436804$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fuhrman, Bianca</creatorcontrib><creatorcontrib>Khateeb, Jasmin</creatorcontrib><creatorcontrib>Shiner, Maayan</creatorcontrib><creatorcontrib>Nitzan, Orna</creatorcontrib><creatorcontrib>Karry, Rachel</creatorcontrib><creatorcontrib>Volkova, Nina</creatorcontrib><creatorcontrib>Aviram, Michael</creatorcontrib><title>Urokinase Plasminogen Activator Upregulates Paraoxonase 2 Expression in Macrophages Via an NADPH Oxidase-Dependent Mechanism</title><title>Arteriosclerosis, thrombosis, and vascular biology</title><addtitle>Arterioscler Thromb Vasc Biol</addtitle><description>OBJECTIVE—Macrophage foam cells are characterized by increased oxidative stress. Macrophage urokinase plasminogen activator (uPA) was shown to contribute to atherosclerosis progression. We hypothesized that uPA atherogenicity is related to its ability to increase macrophage oxidative stress. Increased macrophage oxidative stress in turn was shown to enhance PON2 expression. In the present study we investigated the effect of uPA on macrophage PON2 expression in relation to cellular oxidative stress. METHODS AND RESULTS—uPA increased PON2 expression in THP-1 macrophages in a dose-dependent manner. This effect required uPA/uPAR interaction and was abolished by cell treatment with antioxidants. uPA increased macrophage oxidative stress, measured by increased lipid peroxides, reactive oxygen species formation, superoxide anion release, and cell-mediated LDL oxidation. These effects were related to uPA-mediated activation of NADPH oxidase, and could not be reproduced in mouse peritoneal macrophages (MPM) harvested from p47 mice, suggesting a causal relationship between NADPH oxidase activation and the effects of uPA on macrophage oxidative stress and PON2 expression. Finally, MPM from PON2 mice were more susceptible to uPA-induced cellular oxidative stress than wild-type MPM, suggesting that PON2 protects against uPA-stimulated macrophage oxidative stress. CONCLUSIONS—Upregulation of macrophage PON2 may provide a compensatory protective mechanism against uPA-stimulation of macrophage oxidative stress during atherogenesis.</description><subject>Acetophenones - pharmacology</subject><subject>Animals</subject><subject>Antioxidants - pharmacology</subject><subject>Aryldialkylphosphatase - biosynthesis</subject><subject>Aryldialkylphosphatase - genetics</subject><subject>Aryldialkylphosphatase - metabolism</subject><subject>Atherosclerosis (general aspects, experimental research)</subject><subject>Atherosclerosis - enzymology</subject><subject>Atherosclerosis - metabolism</subject><subject>Biological and medical sciences</subject><subject>Blood and lymphatic vessels</subject><subject>Cardiology. Vascular system</subject><subject>Cardiovascular system</subject><subject>Cell Line, Tumor</subject><subject>Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous</subject><subject>Enzyme Activation</subject><subject>Enzyme Induction</subject><subject>Humans</subject><subject>Lipid Peroxidation</subject><subject>Lipoproteins, LDL - metabolism</subject><subject>Macrophages - drug effects</subject><subject>Macrophages - enzymology</subject><subject>Macrophages - metabolism</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>Mice, Inbred C57BL</subject><subject>Mice, Knockout</subject><subject>Miscellaneous</subject><subject>NADPH Oxidases - deficiency</subject><subject>NADPH Oxidases - genetics</subject><subject>NADPH Oxidases - metabolism</subject><subject>Oxidative Stress - drug effects</subject><subject>Pharmacology. Drug treatments</subject><subject>Plant Extracts - pharmacology</subject><subject>Punicaceae</subject><subject>Reactive Oxygen Species - metabolism</subject><subject>Receptors, Cell Surface - deficiency</subject><subject>Receptors, Cell Surface - genetics</subject><subject>Receptors, Cell Surface - metabolism</subject><subject>Receptors, Urokinase Plasminogen Activator</subject><subject>RNA, Messenger - metabolism</subject><subject>Urokinase-Type Plasminogen Activator - metabolism</subject><issn>1079-5642</issn><issn>1524-4636</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkU9v0zAYhy0EYqPwBTggX-CW8vpv0mPYBkXaWA_rrpGXvGnNEruzE9ZJ-_C4awQHy37l5_eT_JiQjwzmjGn2tby5_VYuyzmDYs60BslekVOmuMykFvp1OkO-yJSW_IS8i_E3AEjO4S05YYUUugB5Sp7Xwd9bZyLSVWdib53foKNlPdg_ZvCBrncBN2NnBox0ZYLxe_9Cc3qxT1cxWu-odfTK1MHvtmaTuFtrqHH0V3m-WtLrvW1SIDvHHboG3UCvsN4aZ2P_nrxpTRfxw7TPyPr7xc3ZMru8_vHzrLzMaqlkkUl-ByBQCaFapkXTcqbaPK9VzlWhmWj5AgEaBG0apXgjJBQihwTDAvLaiBn5cuzdBf8wYhyq3sYau8449GOs9IILdXAyI_wIprfEGLCtdsH2JjxVDKqD82pynuaiOjpPoU9T-3jXY_M_MklOwOcJMLE2XRuMq238x3GQKi9eiuSRe_TdgCHed-MjhmqLphu21eH3hAaVcYAC8jRmafFC_AX5X5kp</recordid><startdate>200807</startdate><enddate>200807</enddate><creator>Fuhrman, Bianca</creator><creator>Khateeb, Jasmin</creator><creator>Shiner, Maayan</creator><creator>Nitzan, Orna</creator><creator>Karry, Rachel</creator><creator>Volkova, Nina</creator><creator>Aviram, Michael</creator><general>American Heart Association, Inc</general><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200807</creationdate><title>Urokinase Plasminogen Activator Upregulates Paraoxonase 2 Expression in Macrophages Via an NADPH Oxidase-Dependent Mechanism</title><author>Fuhrman, Bianca ; Khateeb, Jasmin ; Shiner, Maayan ; Nitzan, Orna ; Karry, Rachel ; Volkova, Nina ; Aviram, Michael</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4548-42b003e5335f163df215f77c57258613f29e00de06ad552d34083705f10907ca3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Acetophenones - pharmacology</topic><topic>Animals</topic><topic>Antioxidants - pharmacology</topic><topic>Aryldialkylphosphatase - biosynthesis</topic><topic>Aryldialkylphosphatase - genetics</topic><topic>Aryldialkylphosphatase - metabolism</topic><topic>Atherosclerosis (general aspects, experimental research)</topic><topic>Atherosclerosis - enzymology</topic><topic>Atherosclerosis - metabolism</topic><topic>Biological and medical sciences</topic><topic>Blood and lymphatic vessels</topic><topic>Cardiology. Vascular system</topic><topic>Cardiovascular system</topic><topic>Cell Line, Tumor</topic><topic>Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous</topic><topic>Enzyme Activation</topic><topic>Enzyme Induction</topic><topic>Humans</topic><topic>Lipid Peroxidation</topic><topic>Lipoproteins, LDL - metabolism</topic><topic>Macrophages - drug effects</topic><topic>Macrophages - enzymology</topic><topic>Macrophages - metabolism</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>Mice, Inbred C57BL</topic><topic>Mice, Knockout</topic><topic>Miscellaneous</topic><topic>NADPH Oxidases - deficiency</topic><topic>NADPH Oxidases - genetics</topic><topic>NADPH Oxidases - metabolism</topic><topic>Oxidative Stress - drug effects</topic><topic>Pharmacology. Drug treatments</topic><topic>Plant Extracts - pharmacology</topic><topic>Punicaceae</topic><topic>Reactive Oxygen Species - metabolism</topic><topic>Receptors, Cell Surface - deficiency</topic><topic>Receptors, Cell Surface - genetics</topic><topic>Receptors, Cell Surface - metabolism</topic><topic>Receptors, Urokinase Plasminogen Activator</topic><topic>RNA, Messenger - metabolism</topic><topic>Urokinase-Type Plasminogen Activator - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fuhrman, Bianca</creatorcontrib><creatorcontrib>Khateeb, Jasmin</creatorcontrib><creatorcontrib>Shiner, Maayan</creatorcontrib><creatorcontrib>Nitzan, Orna</creatorcontrib><creatorcontrib>Karry, Rachel</creatorcontrib><creatorcontrib>Volkova, Nina</creatorcontrib><creatorcontrib>Aviram, Michael</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Arteriosclerosis, thrombosis, and vascular biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fuhrman, Bianca</au><au>Khateeb, Jasmin</au><au>Shiner, Maayan</au><au>Nitzan, Orna</au><au>Karry, Rachel</au><au>Volkova, Nina</au><au>Aviram, Michael</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Urokinase Plasminogen Activator Upregulates Paraoxonase 2 Expression in Macrophages Via an NADPH Oxidase-Dependent Mechanism</atitle><jtitle>Arteriosclerosis, thrombosis, and vascular biology</jtitle><addtitle>Arterioscler Thromb Vasc Biol</addtitle><date>2008-07</date><risdate>2008</risdate><volume>28</volume><issue>7</issue><spage>1361</spage><epage>1367</epage><pages>1361-1367</pages><issn>1079-5642</issn><eissn>1524-4636</eissn><coden>ATVBFA</coden><abstract>OBJECTIVE—Macrophage foam cells are characterized by increased oxidative stress. Macrophage urokinase plasminogen activator (uPA) was shown to contribute to atherosclerosis progression. We hypothesized that uPA atherogenicity is related to its ability to increase macrophage oxidative stress. Increased macrophage oxidative stress in turn was shown to enhance PON2 expression. In the present study we investigated the effect of uPA on macrophage PON2 expression in relation to cellular oxidative stress. METHODS AND RESULTS—uPA increased PON2 expression in THP-1 macrophages in a dose-dependent manner. This effect required uPA/uPAR interaction and was abolished by cell treatment with antioxidants. uPA increased macrophage oxidative stress, measured by increased lipid peroxides, reactive oxygen species formation, superoxide anion release, and cell-mediated LDL oxidation. These effects were related to uPA-mediated activation of NADPH oxidase, and could not be reproduced in mouse peritoneal macrophages (MPM) harvested from p47 mice, suggesting a causal relationship between NADPH oxidase activation and the effects of uPA on macrophage oxidative stress and PON2 expression. Finally, MPM from PON2 mice were more susceptible to uPA-induced cellular oxidative stress than wild-type MPM, suggesting that PON2 protects against uPA-stimulated macrophage oxidative stress. CONCLUSIONS—Upregulation of macrophage PON2 may provide a compensatory protective mechanism against uPA-stimulation of macrophage oxidative stress during atherogenesis.</abstract><cop>Philadelphia, PA</cop><cop>Hagerstown, MD</cop><pub>American Heart Association, Inc</pub><pmid>18436804</pmid><doi>10.1161/ATVBAHA.108.166041</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1079-5642
ispartof Arteriosclerosis, thrombosis, and vascular biology, 2008-07, Vol.28 (7), p.1361-1367
issn 1079-5642
1524-4636
language eng
recordid cdi_proquest_miscellaneous_69235184
source MEDLINE; Journals@Ovid Complete; Alma/SFX Local Collection
subjects Acetophenones - pharmacology
Animals
Antioxidants - pharmacology
Aryldialkylphosphatase - biosynthesis
Aryldialkylphosphatase - genetics
Aryldialkylphosphatase - metabolism
Atherosclerosis (general aspects, experimental research)
Atherosclerosis - enzymology
Atherosclerosis - metabolism
Biological and medical sciences
Blood and lymphatic vessels
Cardiology. Vascular system
Cardiovascular system
Cell Line, Tumor
Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous
Enzyme Activation
Enzyme Induction
Humans
Lipid Peroxidation
Lipoproteins, LDL - metabolism
Macrophages - drug effects
Macrophages - enzymology
Macrophages - metabolism
Medical sciences
Mice
Mice, Inbred BALB C
Mice, Inbred C57BL
Mice, Knockout
Miscellaneous
NADPH Oxidases - deficiency
NADPH Oxidases - genetics
NADPH Oxidases - metabolism
Oxidative Stress - drug effects
Pharmacology. Drug treatments
Plant Extracts - pharmacology
Punicaceae
Reactive Oxygen Species - metabolism
Receptors, Cell Surface - deficiency
Receptors, Cell Surface - genetics
Receptors, Cell Surface - metabolism
Receptors, Urokinase Plasminogen Activator
RNA, Messenger - metabolism
Urokinase-Type Plasminogen Activator - metabolism
title Urokinase Plasminogen Activator Upregulates Paraoxonase 2 Expression in Macrophages Via an NADPH Oxidase-Dependent Mechanism
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T19%3A25%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Urokinase%20Plasminogen%20Activator%20Upregulates%20Paraoxonase%202%20Expression%20in%20Macrophages%20Via%20an%20NADPH%20Oxidase-Dependent%20Mechanism&rft.jtitle=Arteriosclerosis,%20thrombosis,%20and%20vascular%20biology&rft.au=Fuhrman,%20Bianca&rft.date=2008-07&rft.volume=28&rft.issue=7&rft.spage=1361&rft.epage=1367&rft.pages=1361-1367&rft.issn=1079-5642&rft.eissn=1524-4636&rft.coden=ATVBFA&rft_id=info:doi/10.1161/ATVBAHA.108.166041&rft_dat=%3Cproquest_cross%3E69235184%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69235184&rft_id=info:pmid/18436804&rfr_iscdi=true